{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:19:01Z","timestamp":1791361141475,"version":"4.3.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Vivian Allison and Daniel J. Pachman Fund"},{"name":"The DenUyl Family Fund"},{"name":"The CureJM Foundation"},{"name":"Clinical and Translational Science Award","award":["UL1TR001422"],"award-info":[{"award-number":["UL1TR001422"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly diagnosed, untreated JDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      We enrolled 140 untreated JDM and 46 age, race and sex matched healthy controls, ages 2\u201317. We selected items from the Juvenile Myositis Registry for analysis. Variables include average ERL density of 8 fingers, average capillary pattern, hemorrhages, and clinical and laboratory correlates. Laboratory data includes Myositis Specific Antibodies (MSA), disease activity scores (DAS), Childhood Myositis Assessment Scale (CMAS), and standard clinical serologic data. The reduced mean ERL density is 5.1\u2009\u00b1\u20091.5\/mm for untreated JDM vs 7.9\u2009\u00b1\u20090.9\/mm for healthy controls,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001, and is associated with DAS-skin,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.27\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014, which did not change within the age range tested. Untreated JDM with MSA Tif-1-\u03b3 had the lowest ERL density, (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037); their ERL patterns were primarily \u201copen\u201d and the presence of hemorrhages in the nailfold matrix was associated with dysphagia (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Decreased JDM ERL density is associated with increased clinical symptoms; nailfold hemorrhages are associated with dysphagia. Duration of untreated disease symptoms and MSA, modify NFC shape. We speculate nailfold characteristics are useful indicators of disease activity in children with JDM before start of therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-023-00903-x","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T22:01:35Z","timestamp":1697148095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-574X","authenticated-orcid":false,"given":"Lauren M.","family":"Pachman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa S.","family":"Klein-Gitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Khojah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"3","key":"903_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49(3):300\u20135. https:\/\/doi.org\/10.1002\/art.11122. PMID: 12794783.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"903_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41598-021-04302-8","volume":"12","author":"EDO Roberson","year":"2022","unstructured":"Roberson EDO, Mesa RA, Morgan GA, Cao L, Marin W, Pachman LM. Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive. Sci Rep. 2022;12(1):275. https:\/\/doi.org\/10.1038\/s41598-021-04302-8. PMID:34997119;PMCID:PMC8741808.","journal-title":"Sci Rep"},{"issue":"1","key":"903_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s41927-020-00150-7","volume":"4","author":"SM Tawalbeh","year":"2020","unstructured":"Tawalbeh SM, Marin W, Morgan GA, Dang UJ, Hathout Y, Pachman LM. Serum protein biomarkers for juvenile dermatomyositis: a pilot study. BMC Rheumatol. 2020;4(1):52. https:\/\/doi.org\/10.1186\/s41927-020-00150-7. PMID:33015544;PMCID:PMC7528471.","journal-title":"BMC Rheumatol"},{"issue":"8","key":"903_CR4","first-page":"1644","volume":"31","author":"RL Smith","year":"2004","unstructured":"Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. J Rheumatol. 2004;31(8):1644\u20139 PMID: 15290747.","journal-title":"J Rheumatol"},{"issue":"2","key":"903_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/art.23299","volume":"58","author":"S Christen-Zaech","year":"2008","unstructured":"Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum. 2008;58(2):571\u20136. https:\/\/doi.org\/10.1002\/art.23299. PMID:18240225;PMCID:PMC2830145.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"903_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502132920706. PMID: 1090839.","journal-title":"N Engl J Med"},{"key":"903_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/978-1-4939-8793-1_35","volume":"1855","author":"EP Trieu","year":"2019","unstructured":"Trieu EP, Targoff IN. SDS-PAGE for 35S immunoprecipitation and immunoprecipitation western blotting. Methods Mol Biol. 2019;1855:417\u201336. https:\/\/doi.org\/10.1007\/978-1-4939-8793-1_35. PMID: 30426436.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"903_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.10924","volume":"49","author":"RK Bode","year":"2003","unstructured":"Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum. 2003;49(1):7\u201315. https:\/\/doi.org\/10.1002\/art.10924. PMID: 12579588.","journal-title":"Arthritis Rheum"},{"issue":"0 11","key":"903_CR9","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63 Suppl 11","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient\/parent global activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63 Suppl 11(0 11):S118\u201357. https:\/\/doi.org\/10.1002\/acr.20532. PMID: 22588740; PMCID: PMC3748930.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"903_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun. 2019;101:48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.001. Epub 2019 Apr 13. PMID: 30992170; PMCID: PMC6580360.","journal-title":"J Autoimmun"},{"issue":"2","key":"903_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/art.21068","volume":"53","author":"LM Pachman","year":"2005","unstructured":"Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum. 2005;53(2):166\u201372. https:\/\/doi.org\/10.1002\/art.21068. PMID: 15818654.","journal-title":"Arthritis Rheum"},{"key":"903_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mvr.2016.09.001","volume":"109","author":"Z Emrani","year":"2017","unstructured":"Emrani Z, Karbalaie A, Fatemi A, Etehadtavakol M, Erlandsson BE. Capillary density: an important parameter in nailfold capillaroscopy. Microvasc Res. 2017;109:7\u201318. https:\/\/doi.org\/10.1016\/j.mvr.2016.09.001. Epub 2016 Sep 7 PMID: 27614146.","journal-title":"Microvasc Res"},{"issue":"1","key":"903_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2223\/JPED.1435","volume":"82","author":"K Nascif","year":"2006","unstructured":"Nascif K, Terreri MT, Len CA, Andrade LE, Hil\u00e1rio MOE. Inflammatory myopathies in childhood: correlation between nailfold capillaroscopy findings and clinical and laboratory data. J Pediatr (Rio J). 2006;82(1):40\u20135. https:\/\/doi.org\/10.2223\/JPED.1435. PMID: 16532146.","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"903_CR14","doi-asserted-by":"publisher","first-page":"069","DOI":"10.1093\/crocol\/otab069","volume":"3","author":"JA Kurowski","year":"2021","unstructured":"Kurowski JA, Patel SR, Wechsler JB, Izaguirre MR, Morgan GA, Pachman LM, et al. Nailfold capillaroscopy as a biomarker in the evaluation of pediatric inflammatory bowel disease. Crohns Colitis 360. 2021;3(4):069. https:\/\/doi.org\/10.1093\/crocol\/otab069. PMID: 34805987; PMCID: PMC8600950.","journal-title":"Crohns Colitis 360"},{"issue":"4","key":"903_CR15","first-page":"739","volume":"21","author":"J Guzman","year":"1994","unstructured":"Guzman J, Petty RE, Malleson PN. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. J Rheumatol. 1994;21(4):739\u201343 PMID: 8035403.","journal-title":"J Rheumatol"},{"issue":"7","key":"903_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/art.41236","volume":"72","author":"J Wienke","year":"2020","unstructured":"Wienke J, Pachman LM, Morgan GA, Yeo JG, Amoruso MC, Hans V, et al. Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a prognostic tool for treatment response in two independent cohorts of patients with juvenile dermatomyositis. Arthritis Rheumatol. 2020;72(7):1214\u201326. https:\/\/doi.org\/10.1002\/art.41236. Epub 2020 May 29. PMID: 32103637; PMCID: PMC7329617.","journal-title":"Arthritis Rheumatol"},{"key":"903_CR17","doi-asserted-by":"crossref","unstructured":"Kassani PH, Ehwerhemuepha L, Kassab R, Gibbs E, Morgan G, Pachman LM. Artificial intelligence for nailfold capillaroscopy analyses \u2013 a proof of concept application in juvenile dermatomyositis. 2023. (in press).","DOI":"10.1038\/s41390-023-02894-7"},{"key":"903_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clicom.2023.06.001","volume":"3","author":"A Wang","year":"2023","unstructured":"Wang A, Khojah A, Morgan G, Pachman LM. Nailfold capillary dropout precedes the presentation of pneumatosis intestinalis and micro-perforation in juvenile dermatomyositis. Clin Immunol Commun. 2023;3:74\u20136.","journal-title":"Clin Immunol Commun"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00903-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T15:35:53Z","timestamp":1703345753000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00903-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00903-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3221979\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Ann & Robert H. Lurie Children's Hospital of Chicago (IRB# 2010\u201314117, 2001\u201311715, 2011\u201314651).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}